» Articles » PMID: 32274866

Persistent Vs Non-persistent Candidaemia in Adult Patients in 2007-2016: A Retrospective Cohort Study

Overview
Journal Mycoses
Specialty Microbiology
Date 2020 Apr 11
PMID 32274866
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Persistent candidaemia (PC) is a recognised complication of candidaemia. Our objective was to evaluate risk factors and clinical significance of PC in adult patients.

Methods: This is a retrospective, cohort study. We compared PC with non-PC. All patients with blood cultures positive for Candida species were identified from a microbiological database in the hospital district of Helsinki and Uusimaa from 2007 to 2016. PC was defined as an isolation of the same Candida species from positive blood culture for ≥5 days.

Results: PC criteria were fulfilled by 75/350 patients (21.4%). No significant difference emerged between persistent and non-persistent cases caused by non-albicans Candida species (37.3% vs 35.1%, P = .742). The length of hospital stay before onset of candidaemia was longer before PC (hospital stay > 7 days; 73.3% vs 59.6%, P = .043). No significant impact on 30-day mortality was observed (20.0% vs 15.5%, P = .422). Using multivariable regression analysis, we found the presence of central venous catheter (CVC) (OR = 2.71, 95% CI 1.31-5.59), metastatic infection foci (OR 3.60, 95% CI 1.66-7.79) and ineffective empirical treatment (OR = 3.31, 95% CI 1.43-7.65) to be independent risk factors for PC. In subgroup analysis, early source control was identified as a protective factor against PC (30.5% vs 57.7%, P = .002).

Conclusion: The presence of CVC, metastatic infection foci and ineffective empirical treatment were independently associated with PC in adult patients. Active search for and treatment of metastatic infection foci and removal of CVC are key elements for preventing PC.

Citing Articles

Clinical Characteristics of Candidemia Due to with Serial Episodes: Insights from 5-Year Data Collection at a Tertiary Hospital in Korea.

Won E, Sung H, Kim M J Fungi (Basel). 2024; 10(9).

PMID: 39330384 PMC: 11433559. DOI: 10.3390/jof10090624.


Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study.

Li Y, Gu C, Yang Y, Ding Y, Ye C, Tang M BMC Infect Dis. 2023; 23(1):369.

PMID: 37264301 PMC: 10233919. DOI: 10.1186/s12879-023-08241-9.


Clinical Features and Outcomes of Persistent Candidemia Caused by versus Non- Species: A Focus on Antifungal Resistance and Follow-Up Blood Cultures.

Kitaya S, Kanamori H, Katori Y, Tokuda K Microorganisms. 2023; 11(4).

PMID: 37110351 PMC: 10142578. DOI: 10.3390/microorganisms11040928.


Recurrent Candidemia: Trends and Risk Factors Among Persons Residing in 4 US States, 2011-2018.

Seagle E, Jackson B, Lockhart S, Jenkins E, Revis A, Farley M Open Forum Infect Dis. 2022; 9(10):ofac545.

PMID: 36324324 PMC: 9620433. DOI: 10.1093/ofid/ofac545.


Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis.

Gao Y, Tang M, Li Y, Niu X, Li J, Fu C PeerJ. 2022; 10:e13594.

PMID: 35726257 PMC: 9206432. DOI: 10.7717/peerj.13594.